The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Barbara Engelhardt moves her computational and statistics lab to Gladstone
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
NEJM study shows strong protection across strains
The leading cancer hospital urges carrier screening to prevent thalassemia burden
Subscribe To Our Newsletter & Stay Updated
